In the past two decades, rapid expansion of knowledge in molecular immunology and in
understanding the tumor-host immune interaction has opened new possibilities for
development of immunotherapies for the treatment of patients with cancer. Immunotherapies
have been created that can successfully treat, and probably cure, selected patients with
metastatic disease. This review will describe the development of human cancer
immunotherapy by considering four sequential questions that have hallmarked progress in …